The ‘BRCA1/2 Genetic Analysis’ test from Viaguard analyses your DNA to assess your risk of developing hereditary breast or ovarian cancer, based on the detection of variants in the BRCA1 or BRCA2 genes.
You’ll receive a report that determines whether you carry the BRCA gene variants associated with a higher risk of breast and ovarian cancer. Results will provide information about the following genetic variants:
